Roche Acquires PathAI in $750M Deal to Expand AI-Powered Pathology Diagnostics
Roche has agreed to acquire Boston-based PathAI for $750 million upfront, aiming to accelerate AI adoption in pathology. The deal, expected to close i...
Roche has agreed to acquire Boston-based PathAI for $750 million upfront, aiming to accelerate AI adoption in pathology. The deal, expected to close i...
A new study in JAMA Network Open reveals that cutting-edge AI chatbots fail to provide accurate medical advice in over 80% of ambiguous cases and 40%...